<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Busse, Gregory</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Duman, Ronald S.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Depression Overview</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">28-29</style></pages><abstract><style  face="normal" font="default" size="100%">This article provided preclinical and clinical evidence on the role of brain derived neurotrophic factor (as well as other neurotrophic factors) in major depressive disorder. Also discussed is the continuation and discontinuation of venlaxafine and its metabolite in refractory depressed patients.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>